Therapeutic Asset Ratings
3,774 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
cd19/cd20 dual-car-t cells
B-Cell Neoplasm
Han weidong
P1/2
CCC
(48)
cd19/cd22-car-transduced t cells
B-precursor ALL
National Cancer Institute (NCI)
P1/2
CCC
(48)
cd19/cd22-car-transduced t cells
Leukemia, Lymphocytic, B Cell
National Cancer Institute (NCI)
P1/2
CCC
(48)
cd19 specific chimeric antigen receptor t cell
Follicular Lymphoma
Pell Bio-Med Technology Co., Ltd.
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Chronic Granulomatous Disease
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Common Variable Immunodeficiency
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Chronic Obstructive Pulmonary Disease
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Hyper-IgE Syndrome
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Hyper-IgM Syndrome
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
T-Cell Immunodeficiency
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Severe Congenital Neutropenia
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Severe Combined Immunodeficiency
Paul Szabolcs
P1/2
CCC
(48)
cd3/cd19 negative allogeneic hematopoietic stem cells
Wiskott-Aldrich Syndrome
Paul Szabolcs
P1/2
CCC
(48)
cd45ra depleted leukocytes
Beta-Thalassemia Major
Paul Szabolcs
P1/2
CCC
(48)
cd45ra depleted leukocytes
Diamond-Blackfan Anemia
Paul Szabolcs
P1/2
CCC
(48)
cd5/cd7 car-t
T Cell Childhood ALL
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T Cell Leukemia
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T-Cell Lymphoma of CNS
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T Cell Prolymphocytic Leukemia
Essen Biotech
P1/2
CCC
(48)
cd5-targeted car-t cells
Precursor T-Cell Acute Lymphoblastic Leukemia
Peking University People's Hospital
P1/2
CCC
(48)
cd7.car/28zeta car t cells
CD7+ Lymphoma
Zhengzhou University
P1/2
CCC
(48)
cd7.car/28zeta car t cells
Relapsed/Refractory Hematologic Malignancies
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
cd7-cart01
T Lymphoblastic Leukemia/Lymphoma
Bambino Gesù Hospital and Research Institute
P1/2
CCC
(48)
Cea-Targeted Car-T
Malignant Pancreatic Neoplasm
Chongqing Precision Biotech Co., Ltd
P1/2
CCC
(48)
Cea-Targeted Car-T
Rectal Carcinoma
Chongqing Precision Biotech Co., Ltd
P1/2
CCC
(48)
Showing 701 to 725 of 3,774 assets
Previous
Page 29 of 151
Next